Insider Stock Trading History of Granner Daryl K


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Granner Daryl K since year 2005. The trader's CIK number is 1238974. At the time of this reporting, Granner Daryl K is the Director of Osi Pharmaceuticals Inc . (stock ticker symbol OSIP). See this page for all insider trading activities at Osi Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Granner Daryl K since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2009-02-03 OSIP Osi Pharmaceuticals Inc Sale 10,000 42.10 420,950
2009-02-03 OSIP Osi Pharmaceuticals Inc Option Ex 10,000 17.67 176,660
2008-10-01 OSIP Osi Pharmaceuticals Inc Option Ex 2,500 20.31 50,782
2008-10-01 OSIP Osi Pharmaceuticals Inc Sale 2,500 48.70 121,750
2008-09-02 OSIP Osi Pharmaceuticals Inc Sale 3,750 50.42 189,075
2008-09-02 OSIP Osi Pharmaceuticals Inc Option Ex 3,750 28.22 105,821
2008-08-01 OSIP Osi Pharmaceuticals Inc Option Ex 3,750 20.31 76,173
2008-08-01 OSIP Osi Pharmaceuticals Inc Sale 3,750 52.27 196,012
2008-07-22 OSIP Osi Pharmaceuticals Inc Sale 5,000 50.00 250,000
2008-07-22 OSIP Osi Pharmaceuticals Inc Option Ex 5,000 36.12 180,625
2008-07-01 OSIP Osi Pharmaceuticals Inc Option Ex 2,700 20.31 54,845
2008-07-01 OSIP Osi Pharmaceuticals Inc Sale 2,700 42.00 113,400
2008-06-30 OSIP Osi Pharmaceuticals Inc Option Ex 7,300 20.31 148,284
2008-06-30 OSIP Osi Pharmaceuticals Inc Sale 7,300 42.02 306,746
2006-12-01 OSIP Osi Pharmaceuticals Inc Sale 5,415 36.06 195,270
2006-12-01 OSIP Osi Pharmaceuticals Inc Option Ex 5,415 6.50 35,197

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Granner Daryl K (Director of Osi Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.